Stock Photo - 16 November 2020, Belgium, Brüssel: European Commission president Ursula von der Leyen gives a virtual press conference in the Berlaymont, the European headquarters on November 16, 2020, in Brussels, Belgium. The European Commission has agreed to purchase up to 405 million doses of a coronavirus vaccine candidate created by the German biotech company CureVac, President Ursula von der Leyen announced today, saying ""We do not know which vaccine will end up being safe and effective. The European Medicines Agency will authorise them only after a robust assessment, and this is why we need a broad portfolio of vaccines based on very different technologies"". - NO WIRE SERVICE Photo: Thierry Monasse/dpa. - Brüssel/Belgium

Stock Photo: 16 November 2020, Belgium, Brüssel: European Commission president Ursula von der Leyen gives a virtual press conference in the Berlaymont.

Searchable keywords

Choose multiple keywords